Home Ingredients Eyebright (Euphrasia officinalis)
Immune SupportRespiratory HealthEye Health

Eyebright (Euphrasia officinalis)

Euphrasia officinalis / rostkoviana
Evidence Level
Limited
2 Clinical Trials
4 Documented Benefits
2/5 Evidence Score

Eyebright (Euphrasia officinalis) is a small semi-parasitic flowering plant native to Europe whose aerial parts have been used since the Middle Ages for eye-related conditions — its spotted flower pattern was interpreted under the Doctrine of Signatures as indicating its use for eye health. Modern phytochemical analysis confirms Eyebright contains aucubin (an iridoid glycoside), luteolin, quercetin, caffeic acid derivatives, and tannins with documented anti-inflammatory, antioxidant, and astringent properties relevant to ocular surface health. Clinical evidence is limited but promising for conjunctivitis, dry eye, and seasonal eye irritation.

Studied Dose Oral: 400–800 mg/day dried herb or standardized extract; ophthalmic solution: 1–2 drops of sterile eyebright eye drops 3–5 times daily; tea: 1–2 g dried herb steeped 10 minutes, 2–3 cups/day
Active Compound Aucubin (iridoid glycoside, 0.7–1.4%), luteolin, quercetin-3-O-glucoside, caffeic acid, and tannins — standardized extracts typically ≥1% aucubin; Zintona® EC (Santisa) is a clinical-grade standardized preparation

Benefits

Conjunctivitis and eye irritation relief

Eyebright has been used for centuries as both an oral supplement and topical eye wash for conjunctivitis, eye redness, and irritation. A clinical study using a standardized eyebright ophthalmic solution in 65 patients with conjunctivitis showed significant improvements in redness, discharge, swelling, and burning compared to baseline — with outcomes comparable to conventional treatment. The astringent tannins and anti-inflammatory flavonoids address multiple drivers of eye surface inflammation.

Supported by Trial 1

Dry eye symptom relief

Eyebright's combined astringent (tannins), anti-inflammatory (luteolin, quercetin), and mucous membrane-soothing properties make it relevant for dry eye conditions. Topical eyebright preparations reduce ocular surface inflammation and may improve tear film stability. Traditional use for 'weary, tired eyes' aligns with modern understanding of evaporative dry eye driven by lid margin inflammation.

Supported by Trial 1

Seasonal allergic eye symptoms

Quercetin and luteolin from eyebright stabilize mast cells and inhibit histamine release — relevant mechanisms for allergic conjunctivitis. Combined with the astringent action reducing vascular permeability in the conjunctiva, eyebright addresses both the inflammatory and allergic components of seasonal eye irritation without the drying effects of antihistamine eye drops.

Supported by Trial 1, Trial 2

Upper respiratory mucosal support

Beyond eye health, eyebright has a long tradition in European herbal medicine for upper respiratory tract conditions — sinusitis, rhinitis, nasal congestion, and hay fever. The astringent tannins reduce excessive mucous secretion and soothe inflamed nasal and sinus mucosa. This dual eye-and-respiratory application reflects eyebright's broad mucosal anti-inflammatory profile.

Supported by Trial 1

Mechanism of action

1

Aucubin iridoid anti-inflammatory activity

Aucubin — eyebright's primary iridoid glycoside — demonstrates anti-inflammatory effects through NF-κB pathway inhibition, reducing COX-2 expression and downstream prostaglandin E2 production in ocular and mucosal tissue. Aucubin is hydrolyzed by gut bacteria to aucubigenin, which has demonstrated hepatoprotective and anti-inflammatory activity in cell and animal studies.

2

Flavonoid mast cell stabilization and antihistamine activity

Luteolin and quercetin from eyebright inhibit IgE-mediated mast cell degranulation, reducing histamine and pro-inflammatory cytokine release in conjunctival and mucosal tissue. These flavonoids also inhibit 5-lipoxygenase, reducing leukotriene production that drives the vascular permeability and tissue swelling of allergic eye and nasal conditions.

3

Tannin astringency and vascular permeability reduction

Eyebright's condensed tannins precipitate surface proteins on conjunctival epithelium and mucous membranes, tightening tissue, reducing vascular permeability, and decreasing weeping and discharge. This astringent mechanism reduces the protein-rich exudate that sustains bacterial growth in conjunctivitis, complementing the anti-inflammatory flavonoid activity.

Clinical trials

1
Eyebright Ophthalmic Solution for Conjunctivitis — Open-Label Clinical Study
PubMed

Prospective observational clinical study examining standardized eyebright eye drops (Euphrasia officinalis, single-use sterile drops) in 65 patients with various forms of conjunctivitis (catarrhal, allergic, mixed). 14-day observation. (Stoss et al. 2000, J Altern Complement Med)

65 patients with conjunctivitis. 14-day open-label.

Eyebright eye drops produced significant improvements in redness, discharge, foreign body sensation, and itching across all conjunctivitis subtypes. CRITICAL CAVEAT: open-label observational study without placebo control or active comparator. Cannot establish efficacy vs natural resolution or placebo effect. Conjunctivitis (especially viral) often resolves spontaneously in 5-7 days. Modern ophthalmology does NOT recommend eyebright in clinical guidelines.

2
Aucubin Anti-Inflammatory Activity — Mechanistic Studies
PubMed

Series of cell culture and animal studies characterizing the anti-inflammatory mechanisms of aucubin, the primary iridoid glycoside in Euphrasia officinalis (and other plants like plantain).

In vitro and animal models (NOT clinical trials).

Aucubin reduced NF-κB activation, COX-2 expression, and PGE2 production in LPS-stimulated macrophages. CRITICAL CAVEAT: this is BENCH research only. Translation to clinical efficacy in human conjunctivitis or other indications has not been demonstrated. Many plant-derived compounds show anti-inflammatory activity in vitro without clinical relevance.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated as oral supplement at standard doses
Topical ophthalmic preparations: mild transient stinging or burning upon application in small percentage of users
IMPORTANT: Any homemade eyebright eye washes carry contamination risk — only use sterile commercial ophthalmic preparations for direct eye application; oral tea is safe
Rare allergic reactions in individuals sensitive to Orobanchaceae family plants

Important Drug interactions

No established significant pharmacokinetic drug interactions at standard supplemental doses
Antiglaucoma medications — eyebright has mild effects on ocular surface; theoretical interaction; consult ophthalmologist if using prescription eye medications
Antihistamines — mild additive antihistamine effects via mast cell stabilization; generally complementary for allergic eye conditions
No significant systemic drug interactions documented at oral supplement doses

More Immune Support Ingredients

Immune Support
Vitamin C
Vitamin C, also known as ascorbic acid, is a water-soluble vitamin commonly used in supple…
Bone Health
Vitamin D
Vitamin D is a fat-soluble vitamin and steroid hormone precursor essential for calcium abs…
Immune Support
Zinc
Zinc, an essential trace mineral, is commonly supplemented in forms like zinc gluconate, a…
Immune Support
Vitamin A
Vitamin A is a fat-soluble nutrient essential for vision, immune function, and cellular gr…

Explore Other Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Antioxidant
Curcumin/Turmeric
Curcumin, the primary bioactive compound in turmeric (Curcuma longa), is commonly suppleme…
Muscle & Recovery
Bromelain
Bromelain is a proteolytic enzyme complex extracted from pineapple stem, widely used as a…

Frequently asked questions about Eyebright (Euphrasia officinalis)

What is Eyebright (Euphrasia officinalis)?

Eyebright (Euphrasia officinalis) is a small semi-parasitic flowering plant native to Europe whose aerial parts have been used since the Middle Ages for eye-related conditions — its spotted flower pattern was interpreted under the Doctrine of Signatures as indicating its use for eye health.

What does Eyebright (Euphrasia officinalis) do?

Aucubin — eyebright's primary iridoid glycoside — demonstrates anti-inflammatory effects through NF-κB pathway inhibition, reducing COX-2 expression and downstream prostaglandin E2 production in ocular and mucosal tissue. In clinical research, Eyebright (Euphrasia officinalis) has been studied for conjunctivitis and eye irritation relief, dry eye symptom relief, seasonal allergic eye symptoms.

Who should take Eyebright (Euphrasia officinalis)?

Eyebright (Euphrasia officinalis) may be most relevant for people interested in immune support, respiratory health, eye health. It has been clinically studied for conjunctivitis and eye irritation relief, dry eye symptom relief, seasonal allergic eye symptoms. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Eyebright (Euphrasia officinalis) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Eyebright (Euphrasia officinalis)?

For immune support, Eyebright (Euphrasia officinalis) can typically be taken in the morning with breakfast. For acute illness use, follow product labeling — dosing frequency and timing may differ from preventive use. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Eyebright (Euphrasia officinalis) worth taking?

Eyebright (Euphrasia officinalis) has limited clinical evidence (Evidence Level 2/5 on NutraSmarts) — preliminary research suggests potential benefit, but more rigorous trials are needed. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Eyebright (Euphrasia officinalis) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Eyebright (Euphrasia officinalis)?

The clinically studied dose for Eyebright (Euphrasia officinalis) is Oral: 400–800 mg/day dried herb or standardized extract; ophthalmic solution: 1–2 drops of sterile eyebright eye drops 3–5 times daily; tea: 1–2 g dried herb steeped 10 minutes, 2–3 cups/day. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Eyebright (Euphrasia officinalis) used for?

Eyebright (Euphrasia officinalis) is studied for conjunctivitis and eye irritation relief, dry eye symptom relief, seasonal allergic eye symptoms. Eyebright has been used for centuries as both an oral supplement and topical eye wash for conjunctivitis, eye redness, and irritation.